Vertex Pharmaceuticals CEO Jeff Leiden stressed that the company's decision to not agree to a steep discount for the cystic fibrosis drug in the UK is not politically motivated, The Guardian reported Thursday.
Member of Parliament Ben Bradshaw noted that US President Donald Trump has accused countries of freeloading because they pay cheaper prices for drugs than Americans.
Leiden, whose firm has been locked in a dispute with NHS regarding the price of Orkambi for two years, said it is "a much more complicated issue" than political machinations.
While Orkambi carries an annual cost of 207 000 pounds in the US, Vertex has offered to cut the cost to 104 000, which NHS called unaffordable.
Leiden said the UK offer represented a 90-percent discount to the price of Orkambi in most European nations.
The news follows reports earlier this week that Vertex has not paid no corporation taxes in the UK over the last five years.
To read more NewsPoints articles, click here.